Roche Must Pay 7 Million For Accutane Injury Drug Toxic Chemicals
Free Case Evaluation From An Experienced Drug Liability Attorney.
Roche Must Pay $7M for Accutane Injury
Hoffman-LaRoche (Roche), the manufacturer of Accutane, has been ordered to pay $7 million to a man whose colon had to be removed after taking the drug – an acne medication also known as isotretinoin. Hundreds of lawsuits have been filed against the drug company over Accutane for allegedly causing Crohn’s disease, depression, and birth defects.
The company had an exclusive patent on the drug for 20 years. However, generic brands of Accutane, Accure (Alphapharm), Aknenormin (Hermal), Amnesteem (Mylan), Ciscutan (Pelpharma), Claravis (Barr), Isohexal (Hexal), Isotroin (Cipla), Oratan (Douglas Pharmaceuticals), and Sotret (Ranbaxy), were released after the company’s patent expired in 2002.
Accutane, introduced in 1982, has been linked to hundreds of cases of Crohn’s disease, a chronic, episodic, inflammatory bowel disease (IBD) that affects the entire wall of the bowel or intestines. In 2007, a jury ordered Roche to pay $2.6 million to a man who developed Crohn’s disease after taking Accutane.
Accutane has also been linked to depression and suicide. The FDA (Food and Drug Administration) revised the label of the drug in 2005 to include the following warning:
In addition to the strengthened risk management program, FDA continues to assess reports of suicide or suicide attempts associated with the use of isotretinoin. All patients treated with isotretinoin should be observed closely for symptoms of depression or suicidal thoughts, such as sad mood, irritability, acting on dangerous impulses, anger, loss of pleasure or interest in social or sports activities, sleeping too much or too little, changes in weight or appetite, school or work performance going down, or trouble concentrating, or for mood disturbance, psychosis, or aggression. Patients should stop isotretinoin and they or their caregiver should contact their health care professional right away if the patient has any of the previously mentioned symptoms. Discontinuation of treatment may be insufficient and further evaluation may be necessary. (source: www.fda.gov/)
Accutane has allegedly been linked to thousands of cases of birth defects and miscarriages. Roche has acknowledged that birth defects may be a result of Accutane use. According to information on Roche’s website, www.rocheusa.com:
Accutane must not be used by female patients who are or may become pregnant. There is an extremely high risk that severe birth defects will result if pregnancy occurs while taking Accutane in any amount, even for short periods of time. Potentially any fetus exposed during pregnancy can be affected. . . . Birth defects which have been documented following Accutane exposure include abnormalities of the face, eyes, ears, skull, central nervous system, cardiovascular system, and [more].
Suffered harm from Accutane? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.
Read more for related video clips.
No matching videos